A recall of the commonly prescribed diabetes drug Metformin has expanded over concerns of high levels of a cancer-causing contaminant, the FDA announced earlier this week. Skip to content Fox 8 ...

The Metformin HCl Extended Release Tablets, USP 500 mg have been found to contain levels of nitrosamine impurities above the ADI limit of 96 ng/day as publish View full recall details at FDA.gov ...

NDMA Prompts Metformin Recall ... determining from a variety of data sources that 96 ng/day for 70 years would result in a one in 100,000 cancer risk. ...

Oil prices rose on Monday, supported by strong factory activity in China, the world's second-largest oil consumer, and escalating tensions in the Middle East, where Israel resumed attacks on ...

One recall, two expansions, one reason: NDMA content over the FDA’s daily limit of 96 nanograms per day. NDMA, N-Nitrosodimethylamine, is classified as a “probable human carcinogen,” meaning ...

So, as was the case with previous metformin recalls, ... He does not work Indianapolis 500 Race Day. Get unlimited digital access #ReadLocal. Try 1 month for $1. CLAIM OFFER. Recalls ...

A voluntary recall of Metformin, a prescription medication for type 2 diabetes patients, has caused alarm among some Snopes readers, with many asking if the drug could cause cancer.

Maryland Heights, MO, SugarMDs, LLC is voluntarily recalling Lot: 22165-003 Advance Glucose Support Supplement in 60, 120 and 180 count bottles to the consumer level. FDA analysis has found the ...

The recall applies to metformin tablets between 500 mg and 750 mg, sold under the brand name Time-Cap Labs, Inc. RELATED STORY: Study Shows Adolescents, Young Adults At Increasing Risk For Prediabetes ...

Babies born to fathers who were taking the common diabetes drug metformin may have a slightly increased risk of certain birth defects, a large new study suggests.. Among over 1 million babies born ...

Metformin and glyburide are both active ingredients in several FDA-approved prescription drugs used to treat type 2 diabetes and should only be available with prescriptions.

Two pharmaceutical companies issued voluntary recalls Monday for metformin, an anti-diabetes drug, due to high levels of a cancer-causing compound, according to a release from the U.S. Food and ...